Public-domain · open source
OpenJurist
← 248 F.3d 1349 - Troy Shockley Excalibur Tool Equipment Co Inc v. Arcan Inc Telesis Corporation Sunex International Inc

Troy Shockley Excalibur Tool Equipment Co Inc v. Arcan Inc Telesis Corporation Sunex International Inc’s Empirical Analysis

248 F.3d 1349 · 2001

Citation profile

49
cited by 49 later decisions
August 2018
most recently cited

18 federal appellate · 9 district ·

Relationships

Relies on Bowen v. Georgetown University Hospital · Gasperini v. Center for Humanities, Inc. · Molins PLC v. Textron, Inc. · Perkin-Elmer Corporation v. Computervision Corporation · Conroy v. Reebok International, Ltd.

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 49 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “A reissued patent shall not abridge or affect the right of any person or that person’s successors in business who, pri- or to the grant of a reissue, made, purchased, offered to sell, or used within the United States, or imported into the United States, anything patented by the reissued patent, to continue the use of, to offer to sell, or to sell to others to be used, offered for sale, used, or imported unless the making, using, offering for sale, or selling of such thing infringes a valid claim of the reissued patent which was in the original patent.”
    3 later decisions quote this exact passage · from the majority
  2. “Each joint tort-feasor is liable for the full amount of damages (up to a full single recovery) suffered by the patentee.”
    3 later decisions quote this exact passage · from the majority
  3. “the continued practice of a process patented by the reissue”
    2 later decisions quote this exact passage · from the majority

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.